Literature DB >> 24825728

How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.

Stuart G Baker1, Ewoud Schuit, Ewout W Steyerberg, Michael J Pencina, Andrew Vickers, Andew Vickers, Karel G M Moons, Ben W J Mol, Karen S Lindeman.   

Abstract

An important question in the evaluation of an additional risk prediction marker is how to interpret a small increase in the area under the receiver operating characteristic curve (AUC). Many researchers believe that a change in AUC is a poor metric because it increases only slightly with the addition of a marker with a large odds ratio. Because it is not possible on purely statistical grounds to choose between the odds ratio and AUC, we invoke decision analysis, which incorporates costs and benefits. For example, a timely estimate of the risk of later non-elective operative delivery can help a woman in labor decide if she wants an early elective cesarean section to avoid greater complications from possible later non-elective operative delivery. A basic risk prediction model for later non-elective operative delivery involves only antepartum markers. Because adding intrapartum markers to this risk prediction model increases AUC by 0.02, we questioned whether this small improvement is worthwhile. A key decision-analytic quantity is the risk threshold, here the risk of later non-elective operative delivery at which a patient would be indifferent between an early elective cesarean section and usual care. For a range of risk thresholds, we found that an increase in the net benefit of risk prediction requires collecting intrapartum marker data on 68 to 124 women for every correct prediction of later non-elective operative delivery. Because data collection is non-invasive, this test tradeoff of 68 to 124 is clinically acceptable, indicating the value of adding intrapartum markers to the risk prediction model.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  AUC; cesarean section; decision curves; receiver operating characteristic curves; relative utility curves

Mesh:

Year:  2014        PMID: 24825728      PMCID: PMC4156533          DOI: 10.1002/sim.6195

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  The numerical measure of the success of predictions.

Authors:  C S Peirce
Journal:  Science       Date:  1884-11-14       Impact factor: 47.728

2.  A clinical prediction model to assess the risk of operative delivery.

Authors:  E Schuit; A Kwee; M E M H Westerhuis; H J H M Van Dessel; G C M Graziosi; J M M Van Lith; J G Nijhuis; S G Oei; H P Oosterbaan; N W E Schuitemaker; M G A J Wouters; G H A Visser; B W J Mol; K G M Moons; R H H Groenwold
Journal:  BJOG       Date:  2012-05-09       Impact factor: 6.531

Review 3.  Assessment of claims of improved prediction beyond the Framingham risk score.

Authors:  Ioanna Tzoulaki; George Liberopoulos; John P A Ioannidis
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

Review 4.  Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.

Authors:  Maarten J G Leening; Moniek M Vedder; Jacqueline C M Witteman; Michael J Pencina; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

5.  Value of information methods for assessing a new diagnostic test.

Authors:  Maggie Hong Chen; Andrew R Willan
Journal:  Stat Med       Date:  2014-01-09       Impact factor: 2.373

6.  Net risk reclassification p values: valid or misleading?

Authors:  Margaret S Pepe; Holly Janes; Christopher I Li
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

7.  The threshold approach to clinical decision making.

Authors:  S G Pauker; J P Kassirer
Journal:  N Engl J Med       Date:  1980-05-15       Impact factor: 91.245

8.  Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Authors:  Stuart G Baker; Amy K Darke; Paul Pinsky; Howard L Parnes; Barnett S Kramer
Journal:  Biostatistics       Date:  2010-02-19       Impact factor: 5.899

9.  Decision curve analysis: a novel method for evaluating prediction models.

Authors:  Andrew J Vickers; Elena B Elkin
Journal:  Med Decis Making       Date:  2006 Nov-Dec       Impact factor: 2.583

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  24 in total

1.  Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.

Authors:  Stuart G Baker
Journal:  J Natl Cancer Inst       Date:  2015-05-07       Impact factor: 13.506

2.  Evaluating Prognostic Markers Using Relative Utility Curves and Test Tradeoffs.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  J Clin Oncol       Date:  2015-06-29       Impact factor: 44.544

3.  AD risk score for the early phases of disease based on unsupervised machine learning.

Authors:  Zheyu Wang; Zhuojun Tang; Yuxin Zhu; Corinne Pettigrew; Anja Soldan; Alden Gross; Marilyn Albert
Journal:  Alzheimers Dement       Date:  2020-07-30       Impact factor: 21.566

4.  The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients.

Authors:  Ronald E Weir; Christopher S Lyttle; David O Meltzer; Tien S Dong; Gregory W Ruhnke
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

5.  Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.

Authors:  Rajesh Kabra; Saket Girotra; Mary Vaughan Sarrazin
Journal:  J Am Coll Cardiol       Date:  2016-08-02       Impact factor: 24.094

6.  Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.

Authors:  Nitin Ohri; Fenghai Duan; Mitchell Machtay; Jeremy J Gorelick; Bradley S Snyder; Abass Alavi; Barry A Siegel; Douglas W Johnson; Jeffrey D Bradley; Albert DeNittis; Maria Werner-Wasik
Journal:  J Natl Cancer Inst       Date:  2015-02-16       Impact factor: 13.506

7.  Evaluating surrogate endpoints, prognostic markers, and predictive markers: Some simple themes.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  Clin Trials       Date:  2014-11-10       Impact factor: 2.486

8.  Predictive Accuracy of a Polygenic Risk Score-Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease.

Authors:  Joshua Elliott; Barbara Bodinier; Tom A Bond; Marc Chadeau-Hyam; Evangelos Evangelou; Karel G M Moons; Abbas Dehghan; David C Muller; Paul Elliott; Ioanna Tzoulaki
Journal:  JAMA       Date:  2020-02-18       Impact factor: 56.272

9.  A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.

Authors:  Hormuzd A Katki; Mark Schiffman
Journal:  Prev Med       Date:  2018-02-14       Impact factor: 4.018

10.  Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.

Authors:  Wen-Yi Yang; Jesus D Melgarejo; Lutgarde Thijs; Zhen-Yu Zhang; José Boggia; Fang-Fei Wei; Tine W Hansen; Kei Asayama; Takayoshi Ohkubo; Jørgen Jeppesen; Eamon Dolan; Katarzyna Stolarz-Skrzypek; Sofia Malyutina; Edoardo Casiglia; Lars Lind; Jan Filipovský; Gladys E Maestre; Yan Li; Ji-Guang Wang; Yutaka Imai; Kalina Kawecka-Jaszcz; Edgardo Sandoya; Krzysztof Narkiewicz; Eoin O'Brien; Peter Verhamme; Jan A Staessen
Journal:  JAMA       Date:  2019-08-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.